Literature DB >> 6784969

Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia.

T Saheki, A Ueda, M Hosoya, K Kusumi, S Takada, M Tsuda, T Katsunuma.   

Abstract

Enzymological and immunochemical analyses of the liver were preformed in seven Japanese patients with citrullinemia. Among the urea cycle enzymes in the liver, only the activity of argininosuccinate synthetase was specifically decreased to 2 to 50% of normal controls. Liver argininosuccinate synthetase of patients was indistinguishable from that of controls when tested immunochemically by Ouchterlony's double immunodiffusion technique with anti-rat argininosuccinate synthetase antiserum. Immunochemical analysis by means of the single radial immunodiffusion revealed that the decrease in the activity of liver argininosuccinate synthetase was explainable by a decrease in the amount of the enzyme protein in five patients, while the decrease in the activity in the other two patients was not accompanied by a decrease of enzyme protein. The Km values for the substrates of liver argininosuccinate synthetase of the former five were similar to those of the control, while the kinetic properties of the latter two were quite different in terms of higher Km values and negative cooperativity. From these results, we consider that citrullinemia may consist of more than one type including qualitative or quantitative abnormalities of argininosuccinate synthetase caused by some defects in certain genes or in the epigenetic processes in the liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6784969     DOI: 10.1016/0009-8981(81)90318-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  29 in total

1.  Hepatocellular carcinoma associated with adult-type citrullinemia.

Authors:  T Ito; K Shiraki; K Sekoguchi; T Yamanaka; K Sugimoto; K Takase; Y Tameda; T Nakano
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Structure of the 5' end region of the human argininosuccinate synthetase gene.

Authors:  Y Jinno; H Nomiyama; S Matuo; K Shimada; I Matsuda; T Saheki
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

3.  Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia.

Authors:  T Yasuda; N Yamaguchi; K Kobayashi; I Nishi; H Horinouchi; M A Jalil; M X Li; M Ushikai; M Iijima; I Kondo; T Saheki
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

4.  mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency.

Authors:  Jingsong Cao; Ding An; Mikel Galduroz; Jenny Zhuo; Shi Liang; Marianne Eybye; Andrea Frassetto; Eishi Kuroda; Aki Funahashi; Jordan Santana; Cosmin Mihai; Kerry E Benenato; E Sathyajith Kumarasinghe; Staci Sabnis; Timothy Salerno; Kimberly Coughlan; Edward J Miracco; Becca Levy; Gilles Besin; Joshua Schultz; Christine Lukacs; Lin Guey; Patrick Finn; Tatsuhiko Furukawa; Paloma H Giangrande; Takeyori Saheki; Paolo G V Martini
Journal:  Mol Ther       Date:  2019-04-23       Impact factor: 11.454

5.  Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation.

Authors:  S Ikeda; M Yazaki; Y Takei; T Ikegami; Y Hashikura; S Kawasaki; M Iwai; K Kobayashi; T Saheki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

6.  Orthotopic liver transplantation for urea cycle enzyme deficiency.

Authors:  S Todo; T E Starzl; A Tzakis; K J Benkov; F Kalousek; T Saheki; K Tanikawa; W A Fenton
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

7.  Level of translatable messenger RNA coding for argininosuccinate synthetase in the liver of the patients with quantitative-type citrullinemia.

Authors:  M Sase; K Kobayashi; Y Imamura; T Saheki; K Nakano; S Miura; M Mori
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

8.  A search for the primary abnormality in adult-onset type II citrullinemia.

Authors:  K Kobayashi; N Shaheen; R Kumashiro; K Tanikawa; W E O'Brien; A L Beaudet; T Saheki
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

9.  Effects of glucagon on urinary excretion of urea and on plasma ammonia level in argininosuccinate synthetase deficiency.

Authors:  S Tamura; S Kawata; K Fukuda; Y Inui; H Kakimoto; H Ishiguro; M Namba; N Kono; Y Matsuzawa
Journal:  J Gastroenterol       Date:  1994-02       Impact factor: 7.527

10.  Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia.

Authors:  K Kobayashi; H Kakinoki; T Fukushige; N Shaheen; H Terazono; T Saheki
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.